Cyberonics VNS Holds Up Against Depression In Two-Year Pilot Trial
Cyberonics' 60-patient pilot study of vagus nerve stimulation (VNS) for depression showed a 45% response rate at one year compared to 31% at the end of a 12-week acute phase
Cyberonics' 60-patient pilot study of vagus nerve stimulation (VNS) for depression showed a 45% response rate at one year compared to 31% at the end of a 12-week acute phase